Literature DB >> 26867493

The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis.

Shashi Bala1, Timea Csak2, Banishree Saha1, James Zatsiorsky1, Karen Kodys1, Donna Catalano1, Abhishek Satishchandran1, Gyongyi Szabo3.   

Abstract

BACKGROUND & AIMS: Alcoholic liver disease (ALD) ranges from fatty liver to inflammation and cirrhosis. miRNA-155 is an important regulator of inflammation. In this study, we describe the in vivo role of miR-155 in ALD.
METHODS: Wild-type (WT) (C57/BL6J) or miR-155 knockout (KO) and TLR4 KO mice received Lieber DeCarli diet for 5weeks. Some mice received corn oil or CCl4 for 2 or 9weeks.
RESULTS: We found that miR-155 KO mice are protected from alcohol-induced steatosis and inflammation. The reduction in alcohol-induced fat accumulation in miR-155 KO mice was associated with increased peroxisome proliferator-activated receptor response element (PPRE) and peroxisome proliferator-activated receptors (PPAR)α (miR-155 target) binding and decreased MCP1 production. Treatment with a miR-155 inhibitor increased PPARγ expression in naïve and alcohol treated RAW macrophages. Alcohol increased lipid metabolism gene expression (FABP4, LXRα, ACC1 and LDLR) in WT mice and this was prevented in KO mice. Alcohol diet caused an increase in the number of CD163(+) CD206(+) infiltrating macrophages and neutrophils in WT mice, which was prevented in miR-155 KO mice. Kupffer cells isolated from miR-155 KO mice exhibited predominance of M2 phenotype when exposed to M1 polarized signals and this was due to increased C/EBPβ. Pro-fibrotic genes were attenuated in miR-155 KO mice after alcohol diet or CCl4 treatment. Compared to WT mice, attenuation in CCl4 induced hydroxyproline and α-SMA was observed in KO mice. Finally, we show TLR4 signaling regulates miR-155 as TLR4 KO mice showed no induction of miR-155 after alcohol diet.
CONCLUSIONS: Collectively our results demonstrated the role of miR-155 in alcohol-induced steatohepatitis and fibrosis in vivo.
Copyright © 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcohol; Fibrosis; Inflammation; PPARα; PPARγ; microRNA

Mesh:

Substances:

Year:  2016        PMID: 26867493      PMCID: PMC4874886          DOI: 10.1016/j.jhep.2016.01.035

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  35 in total

1.  The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1).

Authors:  Rocio T Martinez-Nunez; Fethi Louafi; Tilman Sanchez-Elsner
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

2.  Krüppel-like factor 4 is a transcriptional regulator of M1/M2 macrophage polarization in alcoholic liver disease.

Authors:  Banishree Saha; Shashi Bala; Nooshin Hosseini; Karen Kodys; Gyongyi Szabo
Journal:  J Leukoc Biol       Date:  2015-03-04       Impact factor: 4.962

3.  MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta.

Authors:  Min He; Zhenqun Xu; Tong Ding; Dong-Ming Kuang; Limin Zheng
Journal:  Cell Mol Immunol       Date:  2009-10       Impact factor: 11.530

Review 4.  Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease.

Authors:  Michal Pawlak; Philippe Lefebvre; Bart Staels
Journal:  J Hepatol       Date:  2014-11-01       Impact factor: 25.083

Review 5.  Alcoholic liver disease and the gut-liver axis.

Authors:  Gyongyi Szabo; Shashi Bala
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

6.  The interleukin-17 pathway is involved in human alcoholic liver disease.

Authors:  Arnaud Lemmers; Christophe Moreno; Thierry Gustot; Raphaël Maréchal; Delphine Degré; Pieter Demetter; Patricia de Nadai; Albert Geerts; Eric Quertinmont; Vincent Vercruysse; Olivier Le Moine; Jacques Devière
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

7.  Inositol phosphatase SHIP1 is a primary target of miR-155.

Authors:  Ryan M O'Connell; Aadel A Chaudhuri; Dinesh S Rao; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

Review 8.  Role of neutrophils in the pathogenesis of acute inflammatory liver injury.

Authors:  Shashi K Ramaiah; Hartmut Jaeschke
Journal:  Toxicol Pathol       Date:  2007-10       Impact factor: 1.902

9.  MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis.

Authors:  Timea Csak; Shashi Bala; Dora Lippai; Karen Kodys; Donna Catalano; Arvin Iracheta-Vellve; Gyongyi Szabo
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

10.  Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis.

Authors:  Dian J Chiang; Sanjoy Roychowdhury; Katelyn Bush; Megan R McMullen; Sorana Pisano; Kathryn Niese; Mitchell A Olman; Michele T Pritchard; Laura E Nagy
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

View more
  85 in total

Review 1.  Inflammatory pathways in alcoholic steatohepatitis.

Authors:  Bin Gao; Maleeha F Ahmad; Laura E Nagy; Hidekazu Tsukamoto
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

2.  TanshinoneIIA Alleviates Inflammatory Response and Directs Macrophage Polarization in Lipopolysaccharide-Stimulated RAW264.7 Cells.

Authors:  Shan Gao; Yili Wang; Dan Li; Yuying Guo; Meifeng Zhu; Shixin Xu; Jingyuan Mao; Guanwei Fan
Journal:  Inflammation       Date:  2019-02       Impact factor: 4.092

Review 3.  Liver macrophages in tissue homeostasis and disease.

Authors:  Oliver Krenkel; Frank Tacke
Journal:  Nat Rev Immunol       Date:  2017-03-20       Impact factor: 53.106

4.  Biomarkers of Macrophage Activation and Immune Danger Signals Predict Clinical Outcomes in Alcoholic Hepatitis.

Authors:  Banishree Saha; David Tornai; Karen Kodys; Adeyinka Adejumo; Patrick Lowe; Craig McClain; Mack Mitchell; Arthur McCullough; Srinivasan Dasarathy; Aimee Kroll-Desrosiers; Bruce Barton; Svetlana Radaeva; Gyongyi Szabo
Journal:  Hepatology       Date:  2019-05-27       Impact factor: 17.425

5.  Expression of microRNA-155 in inflammatory cells modulates liver injury.

Authors:  Delia Blaya; Beatriz Aguilar-Bravo; Fengjie Hao; Silvia Casacuberta-Serra; Mar Coll; Luis Perea; Júlia Vallverdú; Isabel Graupera; Elisa Pose; Laura Llovet; Jordi Barquinero; Francisco Javier Cubero; Juan Caballería; Pere Ginès; Pau Sancho-Bru
Journal:  Hepatology       Date:  2018-05-02       Impact factor: 17.425

6.  Alcohol-induced miR-155 and HDAC11 inhibit negative regulators of the TLR4 pathway and lead to increased LPS responsiveness of Kupffer cells in alcoholic liver disease.

Authors:  Shashi Bala; Timea Csak; Karen Kodys; Donna Catalano; Aditya Ambade; Istvan Furi; Patrick Lowe; Yeonhee Cho; Arvin Iracheta-Vellve; Gyongyi Szabo
Journal:  J Leukoc Biol       Date:  2017-06-05       Impact factor: 4.962

Review 7.  Alcoholic liver disease.

Authors:  Helmut K Seitz; Ramon Bataller; Helena Cortez-Pinto; Bin Gao; Antoni Gual; Carolin Lackner; Philippe Mathurin; Sebastian Mueller; Gyongyi Szabo; Hidekazu Tsukamoto
Journal:  Nat Rev Dis Primers       Date:  2018-08-16       Impact factor: 52.329

Review 8.  Targeting inflammation for the treatment of alcoholic liver disease.

Authors:  Ming-Jiang Xu; Zhou Zhou; Richard Parker; Bin Gao
Journal:  Pharmacol Ther       Date:  2017-06-19       Impact factor: 12.310

9.  A small specific-sized hyaluronic acid ameliorates alcoholic liver disease by targeting a small RNA: New hope for therapy?

Authors:  Yong He; Bin Gao
Journal:  Hepatology       Date:  2017-06-26       Impact factor: 17.425

10.  MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease.

Authors:  Abhishek Satishchandran; Aditya Ambade; Sitara Rao; Ying-Chao Hsueh; Arvin Iracheta-Vellve; David Tornai; Patrick Lowe; Benedek Gyongyosi; Jia Li; Donna Catalano; Li Zhong; Karen Kodys; Jun Xie; Shashi Bala; Guangping Gao; Gyongyi Szabo
Journal:  Gastroenterology       Date:  2017-10-04       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.